Base de dados : MEDLINE
Pesquisa : A01.378.800.090 [Categoria DeCS]
Referências encontradas : 11273 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 1128 ir para página                         

  1 / 11273 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29505520
[Au] Autor:Liu H; Tao M; Ding H; Zhang P
[Ad] Endereço:Department of Ultrasonography.
[Ti] Título:Ultrasonographic manifestations of a rare granular cell tumor of the accessory breast: A case report.
[So] Source:Medicine (Baltimore);97(1):e9462, 2018 Jan.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: The ultrasound manifestations of granular cell tumor (GCT) is a consequence of the histopathological characteristic of the tumor and can be distinguished from breast cancer. PATIENT CONCERNS: A GCT is a rare, benign, hyperplasia-based lesion. Approximately 1% to 2% of GCTs are malignant. About 5% to15% of the cases occur in the breast, and it is relatively rare in the axillary accessory breast. There are no effective preventive measures for GCTs, early detection combined with a thorough and wide complete resection of the tumor remains the best treatment for a favorable outcome. DIAGNOSES: A 45-year-old female patient with an axillary mass of more than 3 months duration was examined through physical examination, color Doppler ultrasound and postoperative pathology. INTERVENTIONS: A provisional diagnosis of left axillary lymph node enlargement was made and necessary investigations were advised. OUTCOMES: A differential diagnosis of accessory breast in the left arm pit, possibly malignant, or a solid mass in the left arm pit secondary to chronic inflammation. Postoperative pathology: GCT of axillary accessory breast, with tumor-free margins. Immunohistochemical staining showed strong S-100 positivity, CD68 positivity, and negative periodic acid-Schiff staining. LESSONS: The ultrasound examination can detect GCT mass in the breast/accessory breast and is not easy to misdiagnosis.
[Mh] Termos MeSH primário: Axila/diagnóstico por imagem
Neoplasias da Mama/diagnóstico por imagem
Tumor de Células Granulares/diagnóstico por imagem
[Mh] Termos MeSH secundário: Axila/patologia
Neoplasias da Mama/patologia
Feminino
Tumor de Células Granulares/patologia
Seres Humanos
Meia-Idade
Ultrassonografia Doppler em Cores
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180309
[Lr] Data última revisão:
180309
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180306
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009462


  2 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29443748
[Au] Autor:Zhang F; Zhang J; Meng QX; Zhang X
[Ad] Endereço:Department of Image Institute.
[Ti] Título:Ultrasound combined with fine needle aspiration cytology for the assessment of axillary lymph nodes in patients with early stage breast cancer.
[So] Source:Medicine (Baltimore);97(7):e9855, 2018 Feb.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This study aimed to explore the clinical usefulness of ultrasound-guided fine needle aspiration cytology (USG-FNAC) for the evaluation of axillary lymph nodes in patients with early stage breast cancer (BC) among the Chinese Han female population.Around 124 patients with early stage BC were included in this retrospective study. All patients underwent USG-FNAC (group A). Patients with proven metastasis also underwent axillary lymph node dissection (ALND) (group B). In addition, sentinel lymph node biopsy (SLNB) was performed 2 to 5 hours prior to the surgery.The sensitivity, specificity, accuracy, and positive predictive value (PPV) of axillary ultrasound were 75.0%, 75.0%, 75.0%, and 82.6%, respectively, while for USG-FNAC, they were 80.8%, 100.0%, 88.7%, and 100.0%, respectively. Significant differences were found in specificity, accuracy, and PPV between the 2 procedures (P < .05).The results of this study demonstrated that USG-FNAC was effective for selecting patients with early stage BC using ALND or SLNB among the Chinese Han female population.
[Mh] Termos MeSH primário: Biópsia por Agulha Fina/métodos
Neoplasias da Mama/cirurgia
Linfonodos/cirurgia
Metástase Linfática/diagnóstico
Ultrassonografia de Intervenção/métodos
[Mh] Termos MeSH secundário: Adulto
Idoso
Axila
Neoplasias da Mama/diagnóstico por imagem
Neoplasias da Mama/patologia
Detecção Precoce de Câncer/métodos
Feminino
Seres Humanos
Excisão de Linfonodo
Linfonodos/diagnóstico por imagem
Linfonodos/patologia
Meia-Idade
Estadiamento de Neoplasias
Estudos Retrospectivos
Biópsia de Linfonodo Sentinela/métodos
[Pt] Tipo de publicação:EVALUATION STUDIES; JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180222
[Lr] Data última revisão:
180222
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180215
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009855


  3 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29390502
[Au] Autor:Xu R; Li J; Zhang Y; Jing H; Zhu Y
[Ad] Endereço:Medicine and Life Sciences College of Shandong Academy of Medical Sciences, University of Jinan.
[Ti] Título:Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review.
[So] Source:Medicine (Baltimore);96(51):e9312, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: Occult breast cancer (OBC) is extremely rare in males with neither symptoms in the breast nor abnormalities upon imaging examination. PATIENT CONCERNS: This current case report presents a young male patient who was diagnosed with male OBC first manifesting as axillary lymph node metastasis. The physical and imaging examination showed no primary lesions in either breasts or in other organs. DIAGNOSES: The pathological results revealed infiltrating ductal carcinoma in the axillary lymph nodes. Immunohistochemical (IHC) staining was negative for estrogen receptor (ER), progesterone receptor (PR), cytokeratin (CK)20 and thyroid transcription factor-1 (TTF-1), positive for CK7, gross cystic disease fluid protein-15 (GCDFP-15), epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA), and suspicious positive for human epidermal receptor-2 (Her-2). On basis of IHC markers, particularly such as CK7, CK20 and GCDFP-15, and eliminating other malignancies, male OBC was identified in spite of negativity for hormone receptors. INTERVENTIONS: The patient underwent left axillary lymph node dissection (ALND) but not mastectomy. After the surgery, the patient subsequently underwent chemotherapy and radiotherapy. OUTCOMES: The patient is currently being followed up without any signs of recurrence. LESSONS: Carefully imaging examination and pathological analysis were particularly essential in the diagnosis of male OBC. The guidelines for managing male OBC default to those of female OBC and male breast cancer.
[Mh] Termos MeSH primário: Axila
Neoplasias da Mama Masculina/patologia
Carcinoma Ductal de Mama/patologia
Metástase Linfática
Neoplasias Primárias Desconhecidas/patologia
[Mh] Termos MeSH secundário: Adulto
Axila/diagnóstico por imagem
Axila/patologia
Neoplasias da Mama Masculina/diagnóstico por imagem
Neoplasias da Mama Masculina/terapia
Carcinoma Ductal de Mama/diagnóstico por imagem
Carcinoma Ductal de Mama/terapia
Seres Humanos
Excisão de Linfonodo
Masculino
Neoplasias Primárias Desconhecidas/diagnóstico por imagem
Neoplasias Primárias Desconhecidas/terapia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180220
[Lr] Data última revisão:
180220
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009312


  4 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29205077
[Au] Autor:Ejlertsen B; Offersen BV; Overgaard J; Christiansen P; Jensen MB; Kroman N; Knoop AS; Mouridsen H
[Ad] Endereço:a Danish Breast Cancer Cooperative Group (DBCG) Secretariat and Statistical Office, Rigshospitalet , Copenhagen University Hospital , Copenhagen , Denmark.
[Ti] Título:Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
[So] Source:Acta Oncol;57(1):3-12, 2018 Jan.
[Is] ISSN:1651-226X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Over the past 40 years the Danish Breast Cancer Cooperative Group (DBCG) has made significant contributions to improve outcome and to make treatment of patients with early breast cancer more tolerable through nationwide and international trials evaluating loco-regional and systemic treatments. These trials have been instrumental to establish standards for the treatment of early breast cancer. METHODS: The DBCG 82 trials had a global impact by documenting that the significant gain in loco-regional recurrence from postmastectomy radiation added to systemic therapy was associated with a reduction in distant recurrence and mortality in high-risk pre- and postmenopausal patients. The DBCG trials comparing breast conserving surgery and radiotherapy with mastectomy and more recently the trial of internal mammary node irradiation also had a major impact of practice. The trials initiated by the DBCG 40 years ago on tamoxifen and cyclophosphamide based chemotherapy became instrumental for the development of adjuvant systemic therapy not only due to their positive results but by sharing these important data with other members of the Early Breast Cancer Trialist' Collaborative Group (EBCTCG). Trials from the DBCG have also been important for highlighting the relative importance of anthracyclines and taxanes in the adjuvant setting. Furthermore, DBCG has made a major contribution to the development of aromatase inhibitors and targeted adjuvant treatment for human epidermal growth factor receptor 2 positive breast cancers. RESULTS: The substantial impact of these treatment improvements is illustrated by a 46.7% 10-year overall survival of early breast cancer patients treated in 1978-1987 compared to 71.5% for patients treated 2008-2012. CONCLUSIONS: The trials conducted and implemented by the DBCG appear to have a major impact on the substantial survival improvements in breast cancer.
[Mh] Termos MeSH primário: Neoplasias da Mama/mortalidade
Neoplasias da Mama/terapia
[Mh] Termos MeSH secundário: Antineoplásicos Hormonais/uso terapêutico
Antineoplásicos Imunológicos/uso terapêutico
Axila/cirurgia
Neoplasias da Mama/patologia
Quimioterapia Adjuvante
Ensaios Clínicos como Assunto
Dinamarca/epidemiologia
Fracionamento de Dose
Feminino
Seres Humanos
Cooperação Internacional
Excisão de Linfonodo
Metástase Linfática/radioterapia
Mastectomia
Mastectomia Segmentar
Estudos Multicêntricos como Assunto
Recidiva Local de Neoplasia/mortalidade
Recidiva Local de Neoplasia/terapia
Prognóstico
Radioterapia Adjuvante
Receptor ErbB-2/antagonistas & inibidores
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antineoplastic Agents, Hormonal); 0 (Antineoplastic Agents, Immunological); EC 2.7.10.1 (Receptor, ErbB-2)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180201
[Lr] Data última revisão:
180201
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171206
[St] Status:MEDLINE
[do] DOI:10.1080/0284186X.2017.1408962


  5 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29283534
[Au] Autor:Bryant JR; Hajjar RT; Lumley C; Chaiyasate K
[Ti] Título:Clinical Question: In women who have undergone breast cancer surgery, including lymph node removal, do blood pressure measurements taken in the ipsilateral arm increase the risk of lymphedema?
[So] Source:J Okla State Med Assoc;109(10):474-9, 2016 10.
[Is] ISSN:0030-1876
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Throughout the healthcare industry fears of taking blood pressure in arm of patients who have undergone breast cancer surgery have been propagated for decades and continue to be recommended by multiple medical societies and healthcare organizations. However, these precautions are not well based on evidence-based medicine and may have a more historical and traditional basis. The purpose of this study was to review current evidence-based research as well as current guidelines regarding ipsilateral arm blood pressure measurements in women who have undergone breast surgery for cancer including lymph node removal.
[Mh] Termos MeSH primário: Determinação da Pressão Arterial/estatística & dados numéricos
Linfedema Relacionado a Câncer de Mama/epidemiologia
Neoplasias da Mama/cirurgia
Excisão de Linfonodo
Mastectomia
[Mh] Termos MeSH secundário: Axila
Feminino
Seres Humanos
Fatores de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180123
[Lr] Data última revisão:
180123
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171229
[St] Status:MEDLINE


  6 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29340672
[Au] Autor:Ballman KV; McCall LM; Giuliano AE
[Ad] Endereço:Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
[Ti] Título:Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.
[So] Source:JAMA;319(3):306-307, 2018 01 16.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Axila
Excisão de Linfonodo
[Mh] Termos MeSH secundário: Neoplasias da Mama
Feminino
Seres Humanos
Linfonodos
Biópsia de Linfonodo Sentinela
[Pt] Tipo de publicação:LETTER; COMMENT
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180119
[Lr] Data última revisão:
180119
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180118
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.18318


  7 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29340668
[Au] Autor:Uno H; Hassett MJ; Wei LJ
[Ad] Endereço:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[Ti] Título:Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.
[So] Source:JAMA;319(3):306, 2018 01 16.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Axila
Excisão de Linfonodo
[Mh] Termos MeSH secundário: Neoplasias da Mama
Feminino
Seres Humanos
Linfonodos
Biópsia de Linfonodo Sentinela
[Pt] Tipo de publicação:LETTER; COMMENT
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180119
[Lr] Data última revisão:
180119
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180118
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.18312


  8 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29310336
[Au] Autor:Park JU; Bae HS; Lee SM; Bae J; Park JW
[Ad] Endereço:Department of Plastic and Reconstructive Surgery.
[Ti] Título:Removal of a subdermal contraceptive implant (Implanon NXT) that migrated to the axilla by C-arm guidance: A case report and review of the literature.
[So] Source:Medicine (Baltimore);96(48):e8627, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: To report the distant migration of a subdermal contraceptive implant and to suggest that C arm-guided technique is one of the feasible options for removal of the device migrated to the axilla. PATIENT CONCERNS: A 41-year-old multipara with tingling sensation in the left axilla was referred for removal of an Implanon NXT which could not be palpated by physical examination or detected by ultrasound scanning. Finally, the device was detected by computed tomography and found migrating to the left axilla. DIAGNOSIS: Migration of Implanon NXT to the left axilla abutting the brachial plexus. INTERVENTIONS: The device was removed by C arm-guiding. OUTCOMES: The patient went home without any procedure-related complications. LESSONS: The incidence of distant migration of a subdermal implant is possible and should be checked up regularly. If the device cannot be palpated or detected by ultrasound at the original implanting site, this should be concerned. Since the single-rod subdermal implant is radiopaque, it can be detected by roentgenography. In this case the distant migration was detected in the axilla, therefore using C arm-guided technique is feasible for the removal of the migrating device. After reviewing the literature, totally 10 cases of distant migration were reported including 2 cases of migration which were advanced further to the pulmonary artery as an embolization.
[Mh] Termos MeSH primário: Anticoncepcionais Femininos
Remoção de Dispositivo
Implantes de Medicamento
Migração de Corpo Estranho/diagnóstico por imagem
Migração de Corpo Estranho/cirurgia
Radiografia Intervencionista
[Mh] Termos MeSH secundário: Adulto
Axila/diagnóstico por imagem
Axila/cirurgia
Desogestrel
Feminino
Seres Humanos
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Contraceptive Agents, Female); 0 (Drug Implants); 304GTH6RNH (etonogestrel); 81K9V7M3A3 (Desogestrel)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180115
[Lr] Data última revisão:
180115
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180110
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000008627


  9 / 11273 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29280894
[Au] Autor:DeGregorio V; Izaddoost S
[Ad] Endereço:Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas.
[Ti] Título:Reply: The Split Pectoralis Flap: Combining the Benefits of Pectoralis Major Advancement and Turnover Techniques in One Flap.
[So] Source:Plast Reconstr Surg;141(1):193e-194e, 2018 01.
[Is] ISSN:1529-4242
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Músculos Peitorais/cirurgia
Retalhos Cirúrgicos
[Mh] Termos MeSH secundário: Axila
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; COMMENT
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180108
[Lr] Data última revisão:
180108
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171228
[St] Status:MEDLINE
[do] DOI:10.1097/PRS.0000000000004002


  10 / 11273 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29262280
[Au] Autor:Beltrame A; Staffolani S
[Ad] Endereço:Sacro Cuore Don Calabria Hospital, Negrar, Italy anna.beltrame@sacrocuore.it.
[Ti] Título:Clinical Diagnosis of Hidradenitis Suppurativa.
[So] Source:N Engl J Med;377(25):2474, 2017 Dec 21.
[Is] ISSN:1533-4406
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Axila/patologia
Genitália Masculina/patologia
Hidradenite Supurativa/patologia
[Mh] Termos MeSH secundário: Adulto
Diagnóstico Tardio
Hidradenite Supurativa/diagnóstico
Seres Humanos
Masculino
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180108
[Lr] Data última revisão:
180108
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171221
[St] Status:MEDLINE
[do] DOI:10.1056/NEJMicm1707912



página 1 de 1128 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde